StockClub

ELVN

ELVNEnliven Therapeutics, Inc.$ --
Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

ELVN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -
Operating Income
-34M USD
YoY -27.5%
Net Income
-30M USD
YoY -28.0%
EPS
-0.45$
YoY +2.2%

Revenue

$0
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
Actual
$0 (-)

Net Income

$-103.7M
FY2024 Q1$-22.7M
$-22.7M
Q1
FY2024 Q2$-42.7M
$-42.7M
Q2
FY2024 Q3$-65.8M
$-65.8M
Q3
FY2024 Q4$-89M
$-89M
Q4
FY2025 Q1$-28.5M
$-28.5M
Q1
FY2025 Q2$-53.9M
$-53.9M
Q2
FY2025 Q3$-74M
$-74M
Q3
FY2025 Q4$-103.7M
$-103.7M
Q4
Actual
$-14.7M (-16.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025MISS
Actual:$0
Est:$10,000
FY2025MISS
$0

Analyst Estimates